Form 990 for tax year 2024
Filed by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA.
Totals
- Total revenue
- $521,348,217
- Total expenses
- $578,265,057
- Contributions and grants received
- $1,116,000
- Grants paid
- $43,264,315
- Program service revenue
- $507,993,172
- Investment income
- $11,851,925
- Other revenue
- $387,120
- Total assets, end of year
- $349,012,370
- Total liabilities, end of year
- $190,475,115
- Net assets or fund balances, end of year
- $158,537,255
- Program services expenses (Part IX)
- not reported
- Management and general expenses
- not reported
- Fundraising expenses
- not reported
- Program service expenses (Part III)
- $0
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$1,116,000
-
2a · Program service revenue: MEMBERSHIP DUES
total $508,650,143 · related or exempt $508,650,143
-
2b · Program service revenue: MEETINGS, SECTIONS, STUDIES
total -$656,971 · related or exempt -$656,971
-
2f · All other program service revenue
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
3 · Investment income
total $11,921,705 · excluded $11,921,705
-
6c · Rental income or loss
real property $0 · personal property $0
-
7a · Gross sales of assets other than inventory
securities $3,471,628
-
7b · Less cost or other basis and sales expenses
securities $3,379,957 · other assets $161,451
-
7c · Gain or loss
securities $91,671 · other assets -$161,451
-
7d · Net gain or loss
total -$69,780 · excluded -$69,780
-
11a · Other revenue: MISCELLANEOUS REVENUE
total $387,120 · excluded $387,120
-
11d · All other revenue
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
11e · Other revenue, total
$387,120
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $43,220,385
-
3 · Grants to foreign organizations and individuals
total $43,930
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $23,765,282
-
7 · Other salaries and wages
total $71,694,936
-
8 · Pension plan contributions
total $4,456,530
-
9 · Other employee benefits
total $6,427,347
-
10 · Payroll taxes
total $6,658,410
-
11b · Fees: legal
total $20,599,243
-
11c · Fees: accounting
total $315,609
-
11d · Fees: lobbying
total $167,952,424
-
11f · Fees: investment management
total $265,836
-
11g · Fees: other
total $82,010,503
-
12 · Advertising and promotion
total $27,283,713
-
13 · Office expenses
total $3,005,251
-
14 · Information technology
total $1,823,708
-
16 · Occupancy
total $13,985,438
-
17 · Travel
total $4,809,997
-
19 · Conferences, conventions and meetings
total $3,976,183
-
22 · Depreciation, depletion and amortization
total $3,399,116
-
23 · Insurance
total $719,108
-
24a · Other expenses: MEMBERSHIPS
total $68,250,478
-
24b · Other expenses: RESEARCH STUDIES
total $16,652,218
-
24c · Other expenses: EQUIPMENT EXPENSE
total $4,300,526
-
24d · Other expenses: TAXES-OTHER
total $2,356,120
-
24e · All other expenses
total $292,766
Balance sheet
Part X, book values.
-
2 · Savings and temporary cash investments
beginning of year $221,437,642 · end of year $38,462,581
-
4 · Accounts receivable
beginning of year $1,364,512 · end of year $1,129,636
-
5 · Loans and receivables from officers and key people
beginning of year $0 · end of year $0
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $3,896,851 · end of year $4,230,134
-
10a · Land, buildings and equipment: cost or other basis
$41,789,403
-
10b · Land, buildings and equipment: accumulated depreciation
$11,269,989
-
10c · Land, buildings and equipment, net
beginning of year $25,409,340 · end of year $30,519,414
-
11 · Investments: publicly traded securities
beginning of year $80,262,649 · end of year $90,734,870
-
12 · Investments: other securities
beginning of year $10,811,296 · end of year $133,129,416
-
13 · Investments: program-related
beginning of year $0
-
15 · Other assets
beginning of year $55,768,387 · end of year $50,806,319
-
17 · Accounts payable and accrued expenses
beginning of year $56,663,492 · end of year $63,269,111
-
19 · Deferred revenue
beginning of year $33,997,527 · end of year $29,904,508
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
25 · Other liabilities
beginning of year $97,360,691 · end of year $97,301,496
-
27 · Net assets without donor restrictions
beginning of year $210,928,967 · end of year $158,537,255
Mission and programs · 2024
Mission
PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF IMPORTANT, NEW MEDICINES FOR PATIENTS BY BIOPHARMACEUTICAL RESEARCH COMPANIES.
Activities or mission (Part I)
PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF IMPORTANT NEW MEDICINES FOR PATIENTS BY BIOPHARMACEUTICAL RESEARCH COMPANIES.
-
PUBLIC POLICY ADVOCACY: PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE DISCOVERY OF IMPORTANT NEW MEDICINES FOR PATIENTS BY BIOPHARMACEUTICAL RESEARCH COMPANIES. PHRMA ACHIEVES THIS MISSION BY WORKING WITH, AND ON BEHALF OF, ITS MEMBER COMPANIES BEFORE GOVERNMENTAL AND REGULATORY BODIES IN THE UNITED STATES AND THROUGHOUT THE WORLD IN SUPPORT OF PRO-PATIENT, PRO-INNOVATION POLICIES. SPECIFICALLY, PHRMA ADVOCATES FOR BROAD PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICINES THROUGH A FREE MARKET, WITHOUT GOVERNMENT PRICE CONTROLS; STRONG INTELLECTUAL PROPERTY INCENTIVES; AND TRANSPARENT, EFFICIENT REGULATION AND A FREE FLOW OF INFORMATION TO PATIENTS.
-
MEMBER SERVICES: IN REPRESENTING THE COUNTRY'S LEADING PHARMACEUTICAL RESEARCH AND BIOTECHNOLOGY COMPANIES, PHRMA PROVIDES A FORUM FOR MEMBER COMPANIES TO PARTICIPATE IN DISCUSSIONS OF RELEVANT HEALTH CARE ISSUES AND TO DEVELOP CONSENSUS POSITIONS ON MATTERS OF PUBLIC POLICY ADVOCACY. MEMBER COMPANIES PARTICIPATE IN PHRMA ACTIVITIES THROUGH REPRESENTATION ON THE BOARD OF DIRECTORS, BOARD-LEVEL COMMITTEES, STAFF WORK GROUPS, SECTIONS, AND TASK FORCES. MEMBER COMPANY REPRESENTATIVES ALSO REGULARLY COMMUNICATE WITH PHRMA STAFF.
-
GENERAL EDUCATION ABOUT BIOPHARMACEUTICAL INDUSTRY: PHRMA DISSEMINATES INFORMATION ABOUT BIOPHARMACEUTICAL COMPANIES, THEIR PRODUCTS, AND THEIR BUSINESS, SCIENTIFIC AND PHILANTHROPIC ACTIVITIES THROUGH A WIDE RANGE OF CHANNELS, INCLUDING PROFILES, REPORTS, PRINCIPLES, GUIDELINES, FACT SHEETS, POLICY PAPERS AND OTHER RESOURCES. THESE EFFORTS BOLSTER PHRMA'S ABILITY TO EDUCATE AND INFORM MEMBERS OF THE GENERAL PUBLIC AS WELL AS POLICYMAKERS, THE MEDIA, PATIENTS AND OTHERS IN THE HEALTH CARE COMMUNITY ABOUT THE BIOPHARMACEUTICAL INDUSTRY AND PHRMA'S PUBLIC POLICY ACTIVITIES IN PARTICULAR.
As filed on the 2024 return.
Listed in Part VII
-
Albert Bourla PHD
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 2
-
Daniel O' Day
CHAIR
- Total calculated
- $0
- Hours/week
- 2
-
Paul Hudson
TREASURER
- Total calculated
- $0
- Hours/week
- 2
-
Stephen J Ubl
President & CEO
- Total calculated
- $7,643,016
- From this org
- $5,935,826
- From related orgs
- $0
- Other
- $1,707,190
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $2,330,915
- Bonus
- $3,010,587
- Other
- $594,324
- Deferred
- $1,669,515
- Nontaxable benefits
- $37,675
- Filer's total
- $7,643,016
-
Alexander Hardy
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Anthony ManciniANTHONY MANCINI
DIRECTOR (THRU 08/24)
- Total calculated
- $0
- Hours/week
- 2
-
Ashley Magargee
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Barry Greene
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Bob Lojewski
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Brad Bailey
DIRECTOR (AS OF 08/24)
- Total calculated
- $0
- Hours/week
- 2
-
Chris Boerner PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Chris ROUND
DIRECTOR (THRU 12/24)
- Total calculated
- $0
- Hours/week
- 2
-
Chris Viehbacher
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
David Loew
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
David Ricks
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Douglas L LangaDOUGLAS L LANGA
DIRECTOR (THRU 12/24)
- Total calculated
- $0
- Hours/week
- 2
-
Emma Walmsley
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Herve J Hoppenot
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Jean-Christophe Tellier MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Jean-Michel Boers
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Jennifer Taubert
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Julie Kim
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Ken Keller
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
KEVIN C GORMAN PhD
DIRECTOR (THRU 09/24)
- Total calculated
- $0
- Hours/week
- 2
-
Kyle Gano PHD
DIRECTOR (AS OF 10/24)
- Total calculated
- $0
- Hours/week
- 2
-
Mark ReisenauerMARK REISENAUER
DIRECTOR (THRU 04/24)
- Total calculated
- $0
- Hours/week
- 2
-
Michael Petroutsas
DIRECTOR (AS OF 02/24)
- Total calculated
- $0
- Hours/week
- 2
-
Myrtle PotterMYRTLE POTTER
DIRECTOR (THRU 03/24)
- Total calculated
- $0
- Hours/week
- 2
-
Richard F Pops
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Robert A Bradway
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Robert M Davis
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Sebastian Guth PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Tarek Rabah
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Tatsuyki Yasuno
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Thomas Gibbs
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Vasant Vas Narasimhan MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
James C Stansel
General Counsel & EVP Law, Secretary
- Total calculated
- $2,266,858
- From this org
- $1,761,157
- From related orgs
- $0
- Other
- $505,701
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $853,954
- Bonus
- $901,733
- Other
- $5,470
- Deferred
- $465,334
- Nontaxable benefits
- $40,367
- Filer's total
- $2,266,858
-
Tracey Merchant
CFO & EVP, Administration
- Total calculated
- $1,717,156
- From this org
- $1,340,588
- From related orgs
- $0
- Other
- $376,568
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $600,224
- Bonus
- $636,820
- Other
- $103,544
- Deferred
- $337,537
- Nontaxable benefits
- $39,031
- Filer's total
- $1,717,156
-
Elizabeth Carpenter
EVP, Policy/Research
- Total calculated
- $1,754,111
- From this org
- $1,077,102
- From related orgs
- $0
- Other
- $677,009
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $631,118
- Bonus
- $443,404
- Other
- $2,580
- Deferred
- $672,556
- Nontaxable benefits
- $4,453
- Filer's total
- $1,754,111
-
Lori Reilly
COO
- Total calculated
- $4,523,351
- From this org
- $2,547,833
- From related orgs
- $0
- Other
- $1,975,518
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $1,100,452
- Bonus
- $1,443,151
- Other
- $4,230
- Deferred
- $1,931,043
- Nontaxable benefits
- $44,475
- Filer's total
- $4,523,351
-
Renuka Iyer
EVP, Human Resources
- Total calculated
- $938,162
- From this org
- $652,356
- From related orgs
- $0
- Other
- $285,806
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $437,442
- Bonus
- $209,024
- Other
- $5,890
- Deferred
- $255,500
- Nontaxable benefits
- $30,306
- Filer's total
- $938,162
-
Robert Zirkelbach II
EVP, Public Affairs
- Total calculated
- $1,881,642
- From this org
- $1,190,211
- From related orgs
- $0
- Other
- $691,431
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $635,243
- Bonus
- $547,240
- Other
- $7,728
- Deferred
- $652,831
- Nontaxable benefits
- $38,600
- Filer's total
- $1,881,642
-
Shannon Monsif
EVP, Alliance
- Total calculated
- $1,478,984
- From this org
- $1,115,048
- From related orgs
- $0
- Other
- $363,936
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $544,971
- Bonus
- $541,782
- Other
- $28,295
- Deferred
- $314,920
- Nontaxable benefits
- $49,016
- Filer's total
- $1,478,984
-
Steven Tilton
EVP, Federal Advocacy
- Total calculated
- $1,908,566
- From this org
- $920,326
- From related orgs
- $0
- Other
- $988,240
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $615,096
- Bonus
- $301,000
- Other
- $4,230
- Deferred
- $947,000
- Nontaxable benefits
- $41,240
- Filer's total
- $1,908,566
-
Anne Pritchett
SVP, Policy/Research
- Total calculated
- $2,106,207
- From this org
- $2,066,592
- From related orgs
- $0
- Other
- $39,615
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $87,628
- Bonus
- $927,884
- Other
- $1,051,080
- Deferred
- $34,500
- Nontaxable benefits
- $5,115
- Filer's total
- $2,106,207
-
Jay Taylor
EVP, International
- Total calculated
- $1,338,685
- From this org
- $990,116
- From related orgs
- $0
- Other
- $348,569
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $528,490
- Bonus
- $443,847
- Other
- $17,779
- Deferred
- $304,277
- Nontaxable benefits
- $44,292
- Filer's total
- $1,338,685
-
Kenneth K McKay IV
SVP, State Advocacy
- Total calculated
- $1,221,209
- From this org
- $935,523
- From related orgs
- $0
- Other
- $285,686
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $514,751
- Bonus
- $410,702
- Other
- $10,070
- Deferred
- $244,696
- Nontaxable benefits
- $40,990
- Filer's total
- $1,221,209
-
Michael Woody
SVP, Federal Advocacy
- Total calculated
- $1,464,681
- From this org
- $1,175,941
- From related orgs
- $0
- Other
- $288,740
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $519,097
- Bonus
- $654,704
- Other
- $2,140
- Deferred
- $246,500
- Nontaxable benefits
- $42,240
- Filer's total
- $1,464,681
-
Scott LaGanga
EVP, State Advocacy
- Total calculated
- $1,574,509
- From this org
- $1,199,864
- From related orgs
- $0
- Other
- $374,645
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $581,008
- Bonus
- $613,766
- Other
- $5,090
- Deferred
- $330,551
- Nontaxable benefits
- $44,094
- Filer's total
- $1,574,509
-
Jennifer Bryant
EVP, Policy/Research
- Total calculated
- $1,858,936
- From this org
- $1,858,936
- From related orgs
- $0
- Other
- $0
- Hours/week
- 37.5
Schedule J breakdown matched by us
- Base
- $0
- Bonus
- $0
- Other
- $1,858,936
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $1,858,936
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 1a · First-class or charter travel
- 1a · Travel for companions
- 1a · Tax indemnification and gross-up payments
- 1a · Housing allowance or residence for personal use
- 1a · Health or social club dues or initiation fees
- 1a · Personal services (maid, chauffeur, chef)
- 1b · Written policy on the line-1a expenses
- 2 · Substantiation required before reimbursing expenses
- 3 · Compensation committee
- 3 · Independent compensation consultant
- 3 · Form 990 of other organizations
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
Answered no
- 4a · Severance or change-of-control payment
The filer's explanations (Part III)
- Schedule J, Part I, Line 1a First-class or charter travel
- FIRST CLASS TRAVEL: THE PRESIDENT AND COO ARE AUTHORIZED TO TRAVEL USING FIRST CLASS.
- Schedule J, Part I, Line 1a Travel for companions
- TRAVEL FOR COMPANIONS: COMPANIONS OCCASIONALLY TRAVEL WITH PHRMA EXECUTIVES ON BUSINESS TRAVEL. IN SUCH CASES, COMPANION TRAVEL IS INCLUDED IN THE TAXABLE INCOME OF THE PHRMA EXECUTIVE.
- Schedule J, Part I, Line 1a Housing allowance or residence for personal use
- HOUSING ALLOWANCE: A HOUSING ALLOWANCE IS PROVIDED TO TRACEY MERCHANT, CFO & EVP, ADMINISTRATION. IT IS PAID MONTHLY AND INCLUDED IN HER INCOME ON FORM W-2.
- Schedule J, Part I, Line 1a Health or social club dues or initiation fees
- HEALTH AND WELLNESS BENEFIT: ALL PHRMA EMPLOYEES ARE ELIGIBLE TO PARTICIPATE IN PHRMA'S HEALTH AND WELLNESS BENEFIT UP TO $1,250 ANNUALLY. THE VALUE OF THIS BENEFIT IS CONSIDERED TAXABLE INCOME.
- Schedule J, Part I, Line 1a Personal services
- PERSONAL SERVICES: THE PRESIDENT IS PROVIDED WITH A DRIVER.
- Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan
- SUPPLEMENTAL PAYMENT PLAN RETIREMENT BENEFIT: ANNE PRITCHETT - $1,041,074, JENNIFER BRYANT - $1,848,016 457(F) AND LTIP: PHRMA SPONSORS A NON-QUALIFIED SECTION 457(F) DEFERRED COMPENSATION PLAN AND A LONG-TERM INCENTIVE PLAN. AMOUNTS PAID OUT UNDER THESE PLANS ARE INCLUDED IN PART VII (WHEN PAID) AND SCHEDULE J, RESPECTIVELY (WHEN PAID, EARNED AND REPORTED IN A PRIOR YEAR). PRIOR YEAR PAID CURRENT YEAR AWARDED STEPHEN UBL: $ 1,823,682 $ 1,635,015 LORI REILLY: $ 708,109 $ 916,043 JAMES STANSEL: $ 480,841 $ 430,834 SCOTT LAGANGA: $ 252,470 $ 296,051 TRACEY MERCHANT: $ - $ 303,037 SHANNON MONSIF: $ 241,441 $ 280,420 ROBERT ZIRKELBACH II: $ - $ 321,781 ELIZABETH CARPENTER: $ - $ 316,506 ANNE PRITCHETT: $ 397,102 $ - JAY TAYLOR: $ - $ 269,777 KENNETH K MCKAY IV: $ - $ 210,196 RENUKA IYER: $ - $ 221,000 STEVEN TILTON: $ -$ 312,500 MICHAEL WOODY: $ - $ 212,000
- Schedule J, Part I, Line 4c Equity-based compensation arrangement
- See Line 4B for details.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$6,827,095
GENERAL CONTRIBUTION
-
$5,000,000
GENERAL CONTRIBUTION
-
$4,000,000
GENERAL CONTRIBUTION
-
$875,000
GENERAL CONTRIBUTION
-
GENERAL CONTRIBUTION
-
PHRMA INDEPENDENT EXPENDITURE COMMITTEE
$842,096
POLITICAL CONTRIBUTION
-
CAMPAIGN TO PROTECT PATIENT HEALTH
$660,000
GENERAL CONTRIBUTION
-
GENERAL CONTRIBUTION
-
REPUBLICAN STATE LEADERSHIP COMMITTEE
$550,000
POLITICAL CONTRIBUTION
-
GENERAL CONTRIBUTION
The 10 largest by cash amount. The API serves every itemized grant.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
PHRMA PAC
527 · POLITICAL · CA · controlled entity
Directly controlled by PHRMA
-
PHRMA INDEPENDENT EXPENDITURE COMMITTEE
527 · POLITICAL · CA · controlled entity
Directly controlled by PHRMA
-
PHRMA COLORADO ACTION FUND
527 · POLITICAL · CO · controlled entity
Directly controlled by PHRMA
-
PHRMA BETTER GOVERNMENT COMMITTEE
527 · POLITICAL · DC · controlled entity
Directly controlled by PHRMA
-
527 · POLITICAL · TN · controlled entity
Directly controlled by PHRMA
-
PhRMA California Initiative Fund
527 · POLITICAL · CA · controlled entity
Directly controlled by PHRMA
-
HEALTHY NEVADA PAC
527 · POLITICAL · NV · controlled entity
Directly controlled by PHRMA
-
PHRMA PNW PAC
527 · POLITICAL · ID · controlled entity
Directly controlled by PHRMA
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 14 November 2025
- IRS schema version
- 2024v5.1
- Source object
- 202503189349303315
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.